Search

Search Constraints

You searched for: Author/Creator Stöhr, Wolfgang

Search Results

1. Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial. Issue 10227 (14th March 2020)

2. Brain Perfusion, Regional Volumes, and Cognitive Function in Human Immunodeficiency Virus–positive Patients Treated With Protease Inhibitor Monotherapy. (31st July 2018)

3. Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir–Ritonavir Plus Either Raltegravir or Tenofovir–Emtricitabine: A Substudy of the NEAT001/ANRS143 Trial. (1st February 2017)

5. Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy. (13th November 2016)

6. Factors associated with virological rebound in HIV-infected patients receiving protease inhibitor monotherapy. (13th November 2016)

7. Genital Secretion HIV RNA Shedding in HIV-Positive Patients on Ritonavir-Boosted Protease Inhibitor Monotherapy or Standard Combination ART: A Cross-Sectional Sub-Study from the PIVOT Trial. Issue 1 (January 2020)

8. Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions. Issue 5 (May 2019)

9. Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trial. (21st November 2019)